"Emerging Fusion Protein Technologies Drive Innovation in Targeted Therapies Across Autoimmune, Cancer, Metabolic, and Cardiovascular Diseases" Boston, Dec. 11, 2025 (GLOBE NEWSWIRE) -- According to ...

HCW Biologics presents HCW9206, a novel fusion protein enhancing CAR-T cell therapy's efficacy and cost-effectiveness against diseases. HCW Biologics Inc. has announced promising results from studies ...

To test the accuracy of the Octet ® assay, Fc-fusion protein was spiked into CCM and HCP matrices at known concentrations in the low (10 μg/mL), mid (40 μg/mL), and high (80 μg/mL) ranges of the ...

Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a ...

This highlights an important preclinical model that could be successful in humans. The notoriously persistent, difficult-to-treat, lifelong and contagious virus—which insidiously attacks the ...

Kexing Biopharm Co. Ltd. has outlined progress in its cachexia and autoimmune pipelines, built upon its Kx-Body antibody technology platform and Kx-Fusion fusion protein technology platform.

Pediatric patients with tenosynovial giant cell tumor: Real-world results from an observational registry. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...